Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Hare JI"'
Autor:
Little RA; Centre for Imaging Sciences, Division of Informatics Imaging & Data Sciences, School of Health Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, UK. Electronic address: ross.little@manchester.ac.uk., Barjat H; Formerly AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. Electronic address: herve.barjat@stfc.ac.uk., Hare JI; IMED Oncology, AstraZeneca, Li Ka Shing Centre, Cambridge CB2 0RE, UK. Electronic address: Jennifer.Hare@astrazeneca.com., Jenner M; Formerly AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK., Watson Y; Centre for Imaging Sciences, Division of Informatics Imaging & Data Sciences, School of Health Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, UK. Electronic address: Yvonne.Watson-2@manchester.ac.uk., Cheung S; Centre for Imaging Sciences, Division of Informatics Imaging & Data Sciences, School of Health Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, UK. Electronic address: Susan.Cheung@manchester.ac.uk., Holliday K; Centre for Imaging Sciences, Division of Informatics Imaging & Data Sciences, School of Health Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, UK. Electronic address: kholliday@mcrc.man.ac.uk., Zhang W; Centre for Imaging Sciences, Division of Informatics Imaging & Data Sciences, School of Health Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, UK. Electronic address: weijuan.zhang@merck.com., O'Connor JPB; Division of Cancer Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Sciences Centre, Oxford Road, Manchester M13 9PL, UK. Electronic address: James.O'Connor@manchester.ac.uk., Barry ST; IMED Oncology, AstraZeneca, Li Ka Shing Centre, Cambridge CB2 0RE, UK. Electronic address: Simon.T.Barry@astrazeneca.com., Puri S; AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK. Electronic address: Sanyogitta.Puri@astrazeneca.com., Parker GJM; Centre for Imaging Sciences, Division of Informatics Imaging & Data Sciences, School of Health Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, UK; Bioxydyn Ltd., Rutherford House, Manchester M15 6SZ, UK. Electronic address: geoff.parker@manchester.ac.uk., Waterton JC; Centre for Imaging Sciences, Division of Informatics Imaging & Data Sciences, School of Health Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, UK; Formerly AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK; Bioxydyn Ltd., Rutherford House, Manchester M15 6SZ, UK. Electronic address: john.waterton@manchester.ac.uk.
Publikováno v:
Magnetic resonance imaging [Magn Reson Imaging] 2018 Feb; Vol. 46, pp. 98-105. Date of Electronic Publication: 2017 Nov 14.
Autor:
Delgado-SanMartin JA; Modelling and Simulation, Oncology IMED DMPK, AstraZeneca, Li Ka Shing Centre, Cambridge, CB2 0RE, UK. juan.x.delgado@gsk.com.; Physics Department, University of Aberdeen, Aberdeen, Scotland. juan.x.delgado@gsk.com.; GSK R&D Centre, Gunnels Wood road, Stevenage, SG1 2NY, UK. juan.x.delgado@gsk.com., Hare JI; Bioscience, Oncology IMED, AstraZeneca, Li Ka Shing Centre, Cambridge, CB2 0RE, UK., Davies EJ; Bioscience, Oncology IMED, AstraZeneca, Li Ka Shing Centre, Cambridge, CB2 0RE, UK., Yates JWT; Modelling and Simulation, Oncology IMED DMPK, AstraZeneca, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
Publikováno v:
BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2017 Jun 23; Vol. 17 (1), pp. 88. Date of Electronic Publication: 2017 Jun 23.
Autor:
Delgado-SanMartin JA; Modelling and Simulation, Oncology IMED DMPK, AstraZeneca, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. juan.x.delgado@gsk.com.; Physics Department, University of Aberdeen, Aberdeen, UK. juan.x.delgado@gsk.com.; GSK R&D Centre, Gunnels Wood Road, Stevenage, SG1 2NY, UK. juan.x.delgado@gsk.com., Hare JI; Bioscience, Oncology IMED, AstraZeneca, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Davies EJ; Bioscience, Oncology IMED, AstraZeneca, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Yates JWT; Modelling and Simulation, Oncology IMED DMPK, AstraZeneca, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.
Publikováno v:
BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2017 May 30; Vol. 17 (1), pp. 70. Date of Electronic Publication: 2017 May 30.
Autor:
England RM; AstraZeneca, Pharmaceutical Sciences, Innovative Medicines, Silk Court Business Park, Macclesfield, Cheshire SK10 2NA, United Kingdom.. Electronic address: Richard.England@astrazeneca.com., Hare JI; AstraZeneca, IMED Oncology, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom. Electronic address: Jennifer.Hare@astrazeneca.com., Barnes J; AstraZeneca, Pathological Sciences, Drug Safety and Metabolism, Cambridge, CB4 0WG, United Kingdom., Wilson J; AstraZeneca, IMED Oncology, Li Ka Shing Centre, CRUK Cambridge Institute, Cambridge CB2 0RE, United Kingdom., Smith A; AstraZeneca, IMED Oncology, Li Ka Shing Centre, CRUK Cambridge Institute, Cambridge CB2 0RE, United Kingdom., Strittmatter N; AstraZeneca, Pathological Sciences, Drug Safety and Metabolism, Cambridge, CB4 0WG, United Kingdom., Kemmitt PD; AstraZeneca, IMED Oncology, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom., Waring MJ; Northern Institute for Cancer Research, School of Chemistry, Bedson Building, Newcastle University, Newcastle upon Tyne NE1 7RU, United Kingdom., Barry ST; AstraZeneca, IMED Oncology, Li Ka Shing Centre, CRUK Cambridge Institute, Cambridge CB2 0RE, United Kingdom., Alexander C; School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, United Kingdom., Ashford MB; AstraZeneca, Pharmaceutical Sciences, Innovative Medicines, Silk Court Business Park, Macclesfield, Cheshire SK10 2NA, United Kingdom.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2017 Feb 10; Vol. 247, pp. 73-85. Date of Electronic Publication: 2016 Dec 30.
Autor:
Hare JI; Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom. Electronic address: Jennifer.Hare@astrazeneca.com., Lammers T; Department of Experimental Molecular Imaging, RWTH Aachen University, Aachen 52074, Germany; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands., Ashford MB; Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom., Puri S; Innovative Medicines-Pharmaceutical Sciences, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom., Storm G; Department of Pharmaceutics, Utrecht University, Utrecht 3584 CG, The Netherlands; Department of Targeted Therapeutics, University of Twente, Enschede 7500 AE, The Netherlands., Barry ST; Innovative Medicines-Oncology, AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, United Kingdom.
Publikováno v:
Advanced drug delivery reviews [Adv Drug Deliv Rev] 2017 Jan 01; Vol. 108, pp. 25-38. Date of Electronic Publication: 2016 Apr 29.
Autor:
Delgado-SanMartin JA; Modelling & Simulation Oncology DMPK, AstraZeneca, Cambridge, United Kingdom; Physics Department, University of Aberdeen, Aberdeen, United Kingdom., Hare JI; In vivo bioscience, AstraZeneca, Macclesfield, United Kingdom., de Moura AP; Physics Department, University of Aberdeen, Aberdeen, United Kingdom., Yates JW; Modelling & Simulation Oncology DMPK, AstraZeneca, Cambridge, United Kingdom.
Publikováno v:
PLoS computational biology [PLoS Comput Biol] 2015 Oct 30; Vol. 11 (10), pp. e1004550. Date of Electronic Publication: 2015 Oct 30 (Print Publication: 2015).
Autor:
Delgado San Martin JA; Modelling & Simulation, Oncology DMPK, AstraZeneca, Macclesfield, UK; Physics Department, University of Aberdeen, Aberdeen, UK., Hare JI; Oncology iMed, AstraZeneca, Macclesfield, UK. Electronic address: Jennifer.Hare@astrazeneca.com., Yates JW; Modelling & Simulation, Oncology DMPK, AstraZeneca, Macclesfield, UK., Barry ST; Oncology iMed, AstraZeneca, Macclesfield, UK.
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2015 Jul; Vol. 11 (5), pp. 1247-52. Date of Electronic Publication: 2015 Mar 06.
Autor:
Hare JI; Department of Pharmacology, University of Alberta, Edmonton, Canada., Neijzen RW, Anantha M, Dos Santos N, Harasym N, Webb MS, Allen TM, Bally MB, Waterhouse DN
Publikováno v:
PloS one [PLoS One] 2013 Apr 23; Vol. 8 (4), pp. e62349. Date of Electronic Publication: 2013 Apr 23 (Print Publication: 2013).
Autor:
Thomas AM; Experimental Therapeutics, BC Cancer Agency, Vancouver, BC, Canada. athomas@bccrc.ca, Kapanen AI, Hare JI, Ramsay E, Edwards K, Karlsson G, Bally MB
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2011 Mar 10; Vol. 150 (2), pp. 212-9. Date of Electronic Publication: 2010 Nov 19.